CompletedPhase 3Phase 4ACTRN12613000068763

Pharmacokinetics of Subcutaneous Injection (SC) of Testosterone in an Oil Vehicle: Nandrolone (ND) in Healthy Volunteers


Sponsor

Sydney Local Health District

Enrollment

12 participants

Start Date

Apr 23, 2013

Study Type

Interventional

Conditions

Summary

Although intramuscular injections of androgen's are known to be effective, they result in varying degrees of pain at the injection site that may last for a day or two. These injections need to be given into a precise location of the buttocks and require staff with expert training. Unlike many other injections these cannot be self-injected due to the difficulty of safely injecting into the buttocks. A SC injection, if effective, may be given by yourself in your own home, which would be more convenient to avoid extra medical visits as well as saving GP and hospital resources. Many men who require androgen replacement therapy may have bleeding disorders or are on medications that may intentionally slow the ability of their blood to clot. These men have a theoretical risk of bleeding and a very large bruise deep in an important muscle may later become infected and cause significant disability. As a result men using these anti-clotting drugs are usually prescribed other forms of androgen replacement therapy that are not always optimal. A SC injection, if effective, may be used in these men. Nandrolone decanoate (ND) Subcutaneous (SC) will be trialed in healthy volunteers,with a historical, intramuscular (IM) control data set. This is the first stage of a 2 stage research study


Eligibility

Sex: MalesMin Age: 18 YearssMax Age: 55 Yearss

Inclusion Criteria3

  • Healthy male volunteers
  • Aged 18-55 yr
  • Written, informed consent & willing to comply with study requirements

Exclusion Criteria7

  • Contraindication to nanadrolone
  • Seeking fertility in the next year
  • Involved in any professional or recreational activities requiring urine drug screening
  • History of illicit drug abuse within last year
  • History of major psychiatric disease or psychological condition that may limit understanding and compliance with study requirements
  • Regular medications that interfere with absorption, metabolism or action of testosterone
  • Taking medications for antiplatelet or anticoagulant therapy

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Nandrolone Decanoate (ND) 100 mg in 2 mL oil vehicle administered as a single subcutaneous injection under the abdominal skin.

Nandrolone Decanoate (ND) 100 mg in 2 mL oil vehicle administered as a single subcutaneous injection under the abdominal skin.


Locations(1)

Concord Repatriation Hospital - Concord

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12613000068763